"Designing Growth Strategies is in our DNA"

U.S. Hemostats Market Size, Share & COVID-19 Impact Analysis, By Product (Active Hemostats, Passive Hemostats, Combination Hemostats, and Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery and Others), By End User (Hospitals & ASCs, Tactical Combat Casualty Care Centers, and Others), and Country Forecast, 2023-2030

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI108837

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Key Surgical Procedures in the U.S.
    2. Epidemiology of Key Diseases in the U.S.
    3. New Product Launches, By Key Players
    4. Key Industry Development: Mergers, Acquisitions, and Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Hemostats Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Active Hemostats
        1. Thrombin-based Hemostats
        2. Fibrin Sealants
      2. Passive Hemostats
        1. Plant-based Hemostats
        2. Animal-based Hemostats
        3. Others
      3. Combination Hemostats
      4. Others
    2. Market Analysis, Insights and Forecast – By Application
      1. Trauma
      2. Cardiovascular Surgery
      3. General Surgery
      4. Plastic Surgery
      5. Orthopedic Surgery
      6. Neurosurgery
      7. Others
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & ASCs
      2. Tactical Combat Casualty Care Centers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Baxter
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Integra LifeSciences
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Stryker
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Artivion, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Biom'up
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. BD (Becton, Dickinson and Company)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Medtronic
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Pfizer Inc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1: U.S. Hemostats Market Revenue Breakdown (USD Billion, %), By Product, 2022 & 2030

Figure 2: U.S. Hemostats Market Value Share (%), by Product, 2022 & 2030

Figure 3: U.S. Hemostats Market Value Share (%), by Application, 2022 & 2030

Figure 4: U.S. Hemostats Market Value Share (%), by End User, 2022 & 2030

Figure 5: U.S. Hemostats Market Share (%), By Company, 2022

Table 1: U.S. Hemostats Market Revenue (USD Billion) Forecast, by Product, 2019–2030

Table 2: U.S. Hemostats Market Revenue (USD Billion) Forecast, by Active Hemostats, 2019–2030

Table 3: U.S. Hemostats Market Revenue (USD Billion) Forecast, by Passive Hemostats, 2019–2030

Table 4: U.S. Hemostats Market Revenue (USD Billion) Forecast, by Application, 2019–2030

Table 5: U.S. Hemostats Market Revenue (USD Billion) Forecast, by End User, 2019–2030

U.S. Hemostats Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Consulting Services
    How will you benefit from our consulting services ?